CY1105116T1 - Χρηση των il-6r/il-6 χιμαιρων στη νοσο του huntington - Google Patents

Χρηση των il-6r/il-6 χιμαιρων στη νοσο του huntington

Info

Publication number
CY1105116T1
CY1105116T1 CY20061101058T CY061101058T CY1105116T1 CY 1105116 T1 CY1105116 T1 CY 1105116T1 CY 20061101058 T CY20061101058 T CY 20061101058T CY 061101058 T CY061101058 T CY 061101058T CY 1105116 T1 CY1105116 T1 CY 1105116T1
Authority
CY
Cyprus
Prior art keywords
huntington
disease
chimeras
derivative
mutein
Prior art date
Application number
CY20061101058T
Other languages
English (en)
Inventor
Nicole Deglon
Patrick Aebischer
Jean-Charles Bensadoun
Original Assignee
Ares Trading S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading S.A. filed Critical Ares Trading S.A.
Publication of CY1105116T1 publication Critical patent/CY1105116T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Abstract

Η εφεύρεση αφορά τη χρήση μιας χίμαιρας IL-6R/IL-6, μιας mutein, ισόμορφης, πρωτεΐνης από σύντηξη, λειτουργικού παραγώγου, δραστικού τμήματος ή παραγώγου κυκλικής μετάθεσης ή άλατος αυτής, για την παρασκευή ενός φαρμάκου για τη θεραπεία ή/και την πρόληψη της νόσου του Huntington.
CY20061101058T 2000-09-14 2006-07-28 Χρηση των il-6r/il-6 χιμαιρων στη νοσο του huntington CY1105116T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00120045 2000-09-14
EP01972039A EP1317273B1 (en) 2000-09-14 2001-09-10 Use of il-6r/il-6 chimera in huntington's disease
PCT/EP2001/010442 WO2002022149A1 (en) 2000-09-14 2001-09-10 Use of il-6r/il-6 chimera in huntington's disease

Publications (1)

Publication Number Publication Date
CY1105116T1 true CY1105116T1 (el) 2009-11-04

Family

ID=8169836

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061101058T CY1105116T1 (el) 2000-09-14 2006-07-28 Χρηση των il-6r/il-6 χιμαιρων στη νοσο του huntington

Country Status (13)

Country Link
US (3) US20040057928A1 (el)
EP (1) EP1317273B1 (el)
JP (1) JP5030364B2 (el)
AT (1) ATE324906T1 (el)
AU (2) AU2001291849B2 (el)
CA (1) CA2419954C (el)
CY (1) CY1105116T1 (el)
DE (1) DE60119347T2 (el)
DK (1) DK1317273T3 (el)
ES (1) ES2262680T3 (el)
IL (2) IL154777A0 (el)
PT (1) PT1317273E (el)
WO (1) WO2002022149A1 (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL147412A0 (en) * 2001-12-31 2002-08-14 Yeda Res & Dev The use of il6r/il6 chimera in nerve cell regeneration
WO2004037281A1 (en) * 2002-10-24 2004-05-06 The University Of British Columbia Methods for neuroprotection
US7553930B2 (en) 2003-01-06 2009-06-30 Xencor, Inc. BAFF variants and methods thereof
AU2004247961B2 (en) * 2003-06-12 2010-06-24 Yeda Research & Development Co.Ltd Enhancement of oligodendrocyte differentiation
AU2004279895A1 (en) 2003-10-10 2005-04-21 Xencor, Inc Protein based TNF-alpha variants for the treatment of TNF-alpha related disorders
SI2859015T1 (sl) 2012-06-08 2018-12-31 Alkermes Pharma Ireland Limited Ligandi, modificirani s cirkularno permutacijo, kot agonisti in antagonisti

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637483A (en) * 1991-10-04 1997-06-10 Whitehead Institute For Biomedical Research Irradiated tumor cell vaccine engineered to express GM-CSF
IL99803A (en) * 1991-10-20 1997-02-18 Yeda Res & Dev Pharmaceutical compositions comprising interleukin-6 for the treatment of chronic lymphocytic leukemia and B-cell lymphomas
US5792900A (en) * 1991-10-21 1998-08-11 The Trustees Of The University Of Pennsylvania Compositions and methods for producing and using homogenous neuronal cell transplants
IL122818A0 (en) * 1997-07-10 1998-08-16 Yeda Res & Dev Chimeric interleukin-6 soluble receptor/ligand protein analogs thereof and uses thereof
DK1895010T3 (da) * 1997-12-22 2011-11-21 Oxford Biomedica Ltd Vektorer baseret på virus for infektiøs hesteanæmi (eiav)
JP4859153B2 (ja) * 1999-02-25 2012-01-25 東ソー株式会社 新規神経系細胞分化促進剤
IL130586A0 (en) * 1999-06-21 2000-06-01 Yeda Res & Dev IL6RIL6 chimera for the treatment of demyelinating diseases

Also Published As

Publication number Publication date
IL154777A (en) 2010-11-30
PT1317273E (pt) 2006-09-29
AU9184901A (en) 2002-03-26
AU2001291849B2 (en) 2005-11-24
US20040057928A1 (en) 2004-03-25
CA2419954C (en) 2012-01-03
JP5030364B2 (ja) 2012-09-19
US20100166703A1 (en) 2010-07-01
US8329654B2 (en) 2012-12-11
WO2002022149A1 (en) 2002-03-21
IL154777A0 (en) 2003-10-31
ES2262680T3 (es) 2006-12-01
DE60119347T2 (de) 2007-02-22
ATE324906T1 (de) 2006-06-15
JP2004508409A (ja) 2004-03-18
EP1317273B1 (en) 2006-05-03
DK1317273T3 (da) 2006-09-04
CA2419954A1 (en) 2002-03-21
DE60119347D1 (de) 2006-06-08
US20070172454A1 (en) 2007-07-26
EP1317273A1 (en) 2003-06-11

Similar Documents

Publication Publication Date Title
EA200301165A1 (ru) Лекарственное средство на основе оксикодона
BR0311313A (pt) Derivados de diaril uréia úteis para o tratamento de doenças dependentes de proteìna cinase
CY1111193T1 (el) Ανθρωπινα cdr-μοσχευμενα αντισωματα και θραυσματα αντισωματων τους
BR0308090A (pt) conjugados de agentes citotóxicos ou terapêuticos e peptìdios biologicamente ativos
EA200101156A1 (ru) ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НОВОГО ТИПА НА ОСНОВЕ ОБЛАДАЮЩИХ ХОЛИНЕРГИЧЕСКИМ ДЕЙСТВИЕМ СОЕДИНЕНИЙ И β-МИМЕТИКОВ
BR0109272A (pt) Agentes conjugados terapêuticos de ácido poliglutâmico, métodos para suas preparações e usos
BRPI0415007A (pt) método para tratar, prevenir, modificar ou administrar dor, e, composição farmacêutica
KR920019342A (ko) 골질환 치료제
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
CY1105116T1 (el) Χρηση των il-6r/il-6 χιμαιρων στη νοσο του huntington
CY1105362T1 (el) Παραγωγα σουλφοναμιδιου, η παρασκευη τους και η εφαρμογη αυτων ως φαρμακα
EA200300503A1 (ru) Новые лекарственные композиции на основе солей тиотропия и солей салметерола
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
EA200400536A1 (ru) Макролиды
CY1112376T1 (el) Παραγωγα 2,3,4,9-τετραϋδρο-1η-καρβαζολης ως ανταγωνιστες του υποδοχεα crth2
CY1109868T1 (el) Cd81 πρωτεϊνη υποδοχεας ηπατιτιδας c
EA200300507A1 (ru) Радиофармацевтические агенты для диагностики болезни альцгеймера
CY1106092T1 (el) Χρηση του μακρου μοριου της πεντραξινης ρτχ3 για τη θepαπεια ασθενειων που προκαλουνται απο μια μεταβαλλομενη ενepγοποιηση του αυξητικου παραγοντα fgf-2
DK0998287T3 (da) Anvendelse af levobupivacain
BRPI0414215A (pt) tienopirazóis
SE9704644D0 (sv) New use
BRPI0409359A (pt) análogos quiméricos de somatostatina-dopamina
CY1107231T1 (el) Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης
SE0102147D0 (sv) New methods
EA200400399A1 (ru) Способы лечения легочных заболеваний